OrganiGram Holdings Inc. (OGI) News
Filter OGI News Items
OGI News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
OGI News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest OGI News From Around the Web
Below are the latest news stories about ORGANIGRAM HOLDINGS INC that investors may wish to consider to help them evaluate OGI as an investment opportunity.
Why OrganiGram (OGI) Is Among the Best Pot Stocks to Invest in According to Analysts?We recently compiled a list of the 10 Best Pot Stocks To Invest In According to Analysts. In this article, we are going to take a look at where OrganiGram (NASDAQ:OGI) stands against other pot stocks to buy according to analysts. The global marijuana market is growing and the market for legal cannabis is expected […] |
Organigram Reports Fourth Quarter and Fiscal 2024 ResultsTORONTO, December 20, 2024--This earnings release replaces the previously filed earnings release on December 18, 2024 to correct errors in the outstanding share data tables under the heading "CAPITAL STRUCTURE." No other changes are being made. The Company is also refiling its Management’s Discussion and Analysis for the twelve months ended September 30, 2024 to correct corresponding errors in the outstanding share data table, which corrections will also apply to the MD&A included in the Company |
OrganiGram Holdings Inc (OGI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...OrganiGram Holdings Inc (OGI) reports a 22% year-over-year revenue increase and strategic international expansions, despite a net loss improvement. |
Organigram (OGI) Q4 2024 Earnings Call TranscriptOGI earnings call for the period ending September 30, 2024. |
OrganiGram: Fiscal Q4 Earnings SnapshotTORONTO (AP) — OrganiGram Holdings Inc. OGI) on Wednesday reported a loss of $4 million in its fiscal fourth quarter. The Toronto-based company said it had a loss of 4 cents per share. |
Organigram Acquires Motif Labs, Becomes Canada’s Largest Cannabis CompanyOrganiGram Holdings ( (TSE:OGI) ) just unveiled an announcement. Organigram Holdings Inc. announced the acquisition of Motif Labs Ltd., establishing itself as Canada’s largest cannabis company by market share. This strategic acquisition enhances Organigram’s position in the Canadian recreational cannabis market, particularly in the vape and infused pre-roll segments, and supports its vision to expand globally. The acquisition is expected to generate significant cost synergies and improve market |
Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024TORONTO, December 11, 2024--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and fiscal 2024 ended September 30, 2024, on Wednesday, December 18, 2024, prior to market open. |
Weekly Roundup on the Cannabis Sector & Psychedelic SectorKey Takeaways; Cannabis Sector Organigram acquired Motif Labs in a transformational move that will make the company Canada’s new cannabis leader Safe Harbor Financial leads the charge in sustainable cannabis financing with $500K loan Rubicon Organics secured CA$10 million in credit to strengthen its financial position Glass House Brands is seeking $25 million for expansion […] |
Organigram Up 2% In US Premarket As Buys Motif; Says To Become Canada's "Largest Cannabis Company by Market Share"Organigram Holdings Inc. (NASDAQ and TSX: OGI), a licensed producer of cannabis, was up 2% in US pre |
Organigram Acquires Motif, Becoming Canada’s Largest Cannabis Company by Market ShareTORONTO, December 06, 2024--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce the acquisition of 100% of the issued and outstanding shares of Motif Labs Ltd. ("Motif"), for upfront consideration of $90 million, consisting of $50 million in cash and $40 million of Organigram common shares priced based on the 30 day trading VWAP of $2.3210 on the Toronto Stock Exchange ("TSX"). In addition, Motif shar |